Cargando…

Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer”

Detalles Bibliográficos
Autores principales:	Daly, Louise E., Ryan, Aoife M., Power, Derek G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2016
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477930/ https://www.ncbi.nlm.nih.gov/pubmed/27480154 http://dx.doi.org/10.1200/JCO.2016.68.8010

Ejemplares similares

Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer
por: Daly, Louise E., et al.
Publicado: (2018)

Muscle loss 6 months after surgery predicts poor survival of patients with non-metastatic colorectal cancer
por: Zhang, Liang, et al.
Publicado: (2022)

The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma
por: Daly, Louise E, et al.
Publicado: (2017)

Postoperative Loss of Skeletal Muscle Mass Predicts Poor Survival After Gastric Cancer Surgery
por: Tan, Shanjun, et al.
Publicado: (2022)

Severe muscle loss during radical chemoradiotherapy for non‐metastatic nasopharyngeal carcinoma predicts poor survival
por: Huang, Xiao, et al.
Publicado: (2019)

Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced‐stage ovarian cancer
por: Huang, Chueh‐Yi, et al.
Publicado: (2020)

Muscle Loss Is Associated with Overall Survival in Patients with Metastatic Colorectal Cancer Independent of Tumor Mutational Status and Weight Loss
por: Best, Till Dominik, et al.
Publicado: (2021)

Skeletal muscle mass loss and dose‐limiting toxicities in metastatic colorectal cancer patients
por: Kurk, Sophie, et al.
Publicado: (2019)

Severe loss of visceral fat and skeletal muscle after chemotherapy predicts poor prognosis in metastatic gastric cancer patients without gastrectomy
por: Feng, Wanjing, et al.
Publicado: (2020)

Poor outcome in patients with acute leukemia on intensive chemotherapy and COVID-19
por: Núñez-Torrón, Claudia, et al.
Publicado: (2020)

Prolonged survival in metastatic colorectal cancer following chemotherapy
por: Paul, Doru, et al.
Publicado: (2014)

Comment on: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery
por: Liu, Kai, et al.
Publicado: (2022)

Loss of expression of Syndecan-1 is associated with Tumor Recurrence, Metastatic Potential, and Poor Survival in patients with Colorectal carcinoma
por: Al-Maghrabi, Jaudah
Publicado: (2021)

No evidence for changes in skeletal muscle mass or weight during first-line chemotherapy for metastatic colorectal cancer
por: Antoun, Sami, et al.
Publicado: (2019)

Skeletal muscle loss during neoadjuvant chemotherapy predicts poor prognosis in patients with breast cancer
por: Amitani, Masatsugu, et al.
Publicado: (2022)

Author response to: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery
por: Rahman, Saqib A, et al.
Publicado: (2022)

Validation study of ultrasonography versus computed tomography for measuring muscle mass loss in critically ill patients: CT mUS study
por: Peres, Leandro Moreira, et al.
Publicado: (2023)

Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway
por: Padella, Antonella, et al.
Publicado: (2021)

Overall Survival by Response to First-line Induction Treatment with Atezolizumab plus Platinum-based Chemotherapy or Placebo plus Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
por: Grande, Enrique, et al.
Publicado: (2023)

Systemic chemotherapy for gastro-oesophagogastric junction adenocarcinoma and stomach adenocarcinoma in a metastatic setting
por: Sanjeevaiah, Aravind, et al.
Publicado: (2020)

Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer
por: Park, Song Ee, et al.
Publicado: (2020)

The implication of BRAF mutation in advanced colorectal cancer
por: O’Riordan, Emma, et al.
Publicado: (2021)

Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer
por: Lee, Jie, et al.
Publicado: (2019)

High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma
por: Chen, Cunte, et al.
Publicado: (2022)

Metastatic melanoma misdiagnosed as lipoma manifesting as a subcutaneous soft-tissue mass
por: An, Qian, et al.
Publicado: (2019)

The relationship between the BMI‐adjusted weight loss grading system and quality of life in patients with incurable cancer
por: Daly, Louise, et al.
Publicado: (2019)

Loss of Villin Immunoexpression in Colorectal Carcinoma Is Associated with Poor Differentiation and Survival
por: Al-Maghrabi, Jaudah, et al.
Publicado: (2013)

The Impact of Palliative Chemotherapy on the Survival of Patients With Metastatic Colorectal Cancer in Jordan
por: Alkader, Mohammad S, et al.
Publicado: (2023)

High SOX2 expression is associated with poor survival in patients with newly diagnosed multiple myeloma
por: Shan, Xinhe, et al.
Publicado: (2023)

Are CT-Derived Muscle Measurements Prognostic, Independent of Systemic Inflammation, in Good Performance Status Patients with Advanced Cancer?
por: McGovern, Josh, et al.
Publicado: (2023)

BAG3 protein expression in melanoma metastatic lymph nodes correlates with patients' survival
por: Guerriero, L, et al.
Publicado: (2014)

Comment on “Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes”
por: Loughrey, Maurice B., et al.
Publicado: (2020)

Overexpression of ASPH protein predicts poor outcomes in retroperitoneal liposarcoma patients
por: Xiao, Mengmeng, et al.
Publicado: (2023)

Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer: a multicenter prospective observational study
por: Wang, Jiani, et al.
Publicado: (2023)

Survival of metastatic colorectal cancer patients treated with chemotherapy in Alberta (1995–2004)
por: Chen, Yiqun, et al.
Publicado: (2009)

Understanding the Relationship between Low Muscle Mass and Depressed Mood in Korean Girls
por: Park, Seon-Cheol
Publicado: (2019)

DLC1 deficiency at diagnosis predicts poor prognosis in acute myeloid leukemia
por: Li, Xueqian, et al.
Publicado: (2022)

Extreme body mass index and survival in newly diagnosed multiple myeloma patients
por: Shah, Urvi A., et al.
Publicado: (2023)

Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer
por: Sartore-Bianchi, Andrea, et al.
Publicado: (2016)

Overexpression of Rab1B and MMP9 predicts poor survival and good response to chemotherapy in patients with colorectal cancer
por: Yang, Xian-Zi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vig5ekbcdp9ih3mg8n6uj9omlk